Unknown

Dataset Information

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.


ABSTRACT:

Background

People with opioid dependence and HIV are concentrated within criminal justice settings (CJS). Upon release, however, drug relapse is common and contributes to poor HIV treatment outcomes, increased HIV transmission risk, reincarceration and mortality. Extended-release naltrexone (XR-NTX) is an evidence-based treatment for opioid dependence, yet is not routinely available for CJS populations.

Methods

A randomized, double-blind, placebo-controlled trial of XR-NTX for HIV-infected inmates transitioning from correctional to community settings is underway to assess its impact on HIV and opioid-relapse outcomes.

Results

We describe the methods and early acceptability of this trial. In addition we provide protocol details to safely administer XR-NTX near communit

SUBMITTER: Di Paola A 

PROVIDER: S-EPMC4283549 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature